John W. Rogers Jr. - Ariel Appreciation Fund 13F Activity & Position Changes (Q1 2024)

According to the SEC 13F filed on May 14, 2024, the Ariel Appreciation Fund portfolio showed several notable changes in holdings as of quarter-end Mar 31, 2024. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q1 2024, the filing reported:

New Buys - Capital One Financial Corporati, CVS Health Corporation, Lazard, Inc., MGP Ingredients, Inc., Teradata Corporation, and 1 more

Increases - ADT Inc., Affiliated Managers Group, Inc., Adtalem Global Education Inc., Bio-Rad Laboratories, Inc., Core Laboratories Inc., and 26 more

Reductions - AFLAC Incorporated, Axalta, Credicorp, Brinks Company (The), Baidu, Inc., and 62 more

Complete Exits - iShares MSCI ACWI ex U.S. ETF, Equity, Fortrea Holdings Inc., Amdocs, GSK plc

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q1 2024	ACWX iShares MSCI ACWI ex U.S. ETF	iShares MSCI ACWI ex U.S. ETF	Sell - Position Exit	-65,769	-100.0%	$0.00	-
Q1 2024	ADT ADT Inc.	ADT Inc.	Buy	+7,131,950	+31.8%	$198.78M	29,579,797
Q1 2024	AFL AFLAC Incorporated	AFLAC Incorporated	Sell	-1,264	-0.2%	$46.20M	538,133
Q1 2024	AMG Affiliated Managers Group, Inc.	Affiliated Managers Group, Inc.	Buy	+84,313	+6.8%	$222.23M	1,327,009
Q1 2024	ATGE Adtalem Global Education Inc.	Adtalem Global Education Inc.	Buy	+306,699	+11.1%	$158.28M	3,079,317
Q1 2024	AXTA Axalta	Axalta	Sell	-303,543	-6.4%	$153.93M	4,475,887
Q1 2024	BAP Credicorp	Credicorp	Sell	-45,969	-7.7%	$93.41M	551,341
Q1 2024	BCO Brinks Company (The)	Brinks Company (The)	Sell	-171,760	-9.1%	$158.22M	1,712,701
Q1 2024	BIDU Baidu, Inc.	Baidu, Inc.	Sell	-388,250	-25.4%	$119.99M	1,139,721
Q1 2024	BIO Bio-Rad Laboratories, Inc.	Bio-Rad Laboratories, Inc.	Buy	+60,615	+1353.9%	$22.51M	65,092
Q1 2024	BMY Bristol-Myers Squibb Company	Bristol-Myers Squibb Company	Sell	-345,635	-35.3%	$34.39M	634,113
Q1 2024	BOKF BOK Financial Corporation	BOK Financial Corporation	Sell	-81,636	-3.7%	$198.20M	2,154,389
Q1 2024	BRC Brady Corporation	Brady Corporation	Sell	-3,616	-1.2%	$17.15M	289,233
Q1 2024	BWA BorgWarner Inc.	BorgWarner Inc.	Sell	-176,211	-14.9%	$34.84M	1,002,790
Q1 2024	BYD Boyd Gaming Corporation	Boyd Gaming Corporation	Sell	-376,458	-12.3%	$181.47M	2,695,707
Q1 2024	CBRE CBRE Group Inc	CBRE Group Inc	Sell	-90,516	-11.4%	$68.60M	705,449
Q1 2024	CG The Carlyle Group Inc.	The Carlyle Group Inc.	Sell	-1,504,398	-23.6%	$229.06M	4,882,920
Q1 2024	CHKP Check Point	Check Point	Sell	-117,589	-7.8%	$226.75M	1,382,533
Q1 2024	CLB Core Laboratories Inc.	Core Laboratories Inc.	Buy	+1,837,258	+20.4%	$184.90M	10,825,657
Q1 2024	CNH CNH Industrial	CNH Industrial	Buy	+795,998	+46.3%	$32.61M	2,516,318
Q1 2024	COF Capital One Financial Corporati	Capital One Financial Corporati	Buy - Position Entry	+263,724	-	$39.27M	263,724
Q1 2024	CRL Charles River Laboratories Inte	Charles River Laboratories Inte	Sell	-117,891	-11.2%	$252.74M	932,807
Q1 2024	CVS CVS Health Corporation	CVS Health Corporation	Buy - Position Entry	+606,609	-	$48.38M	606,609
Q1 2024	DNB Dun & Bradstreet Holdings, Inc.	Dun & Bradstreet Holdings, Inc.	Buy	+161,679	+3.9%	$43.64M	4,346,134
Q1 2024	DVA DaVita Inc.	DaVita Inc.	Sell	-42,548	-6.5%	$85.08M	616,270
Q1 2024	EQC Equity	Equity	Sell - Position Exit	-1,191,361	-100.0%	$0.00	-
Q1 2024	EVR Evercore Inc.	Evercore Inc.	Sell	-36,507	-22.4%	$24.31M	126,243
Q1 2024	FAF First American Corporation (New	First American Corporation (New	Sell	-143,945	-3.9%	$214.44M	3,512,539
Q1 2024	FI Fiserv, Inc.	Fiserv, Inc.	Buy	+301	+7.0%	$737.89K	4,617
Q1 2024	FICO Fair Isaac Corporation	Fair Isaac Corporation	Buy	+24	+6.8%	$469.85K	376

Page 1 of 4